(Q51403187)

4 April 2018

title

RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan). (English)

1 reference

4 April 2018

author name string

Tadao Nakazawa

1

1 reference

4 April 2018

Tetsuo Kondo

2

1 reference

4 April 2018

Yoshihiko Kobayashi

3

1 reference

4 April 2018

Noboru Takamura

4

1 reference

4 April 2018

Shin-ichi Murata

5

1 reference

4 April 2018

Kaori Kameyama

6

1 reference

4 April 2018

Akira Muramatsu

7

1 reference

4 April 2018

Kohichi Ito

8

1 reference

4 April 2018

Makio Kobayashi

9

1 reference

4 April 2018

Ryohei Katoh

10

1 reference

4 April 2018

language of work or name

English

0 references

publication date

1 September 2005

1 reference

4 April 2018

published in

Cancer

1 reference

4 April 2018

volume

104

1 reference

4 April 2018

issue

5

1 reference

4 April 2018

page(s)

943-951

1 reference

4 April 2018

Lack of PTC Gene(ret Proto-oncogene Rearrangement) in Human Thyroid Tumors

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

Analysis of thyroid carcinoma based on material registered in Japan during 1977-1986 with special reference to predominance of papillary type

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

7 January 2021

Activation of a novel human transforming gene, ret, by DNA rearrangement

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

7 January 2021

Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

7 January 2021

Ret oncogene activation in papillary thyroid carcinoma: prevalence and implication on the histological parameters

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

7 January 2021

Prevalence of RET/PTC rearrangements in Hashimoto's thyroiditis and papillary thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

7 January 2021

Oncogene profile of papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

7 January 2021

Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

7 January 2021

Ret/PTC3 is the most frequent form of gene rearrangement in papillary thyroid carcinomas in Japan

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

7 January 2021

ret rearrangements in Japanese pediatric and adult papillary thyroid cancers.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

7 January 2021

Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

7 January 2021

High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

7 January 2021

RET/PTC rearrangement in thyroid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

7 January 2021

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

7 January 2021

Mutation of ras oncogene in di-isopropanolnitrosamine-induced rat thyroid carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

7 January 2021

cDNA cloning and characterization of ret activated in a human papillary thyroid carcinoma cell line

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

7 January 2021

Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

7 January 2021

Prognostic factors in differentiated carcinoma of the thyroid gland

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21270

7 January 2021

Identifiers

DOI

10.1002/CNCR.21270

1 reference

4 April 2018

1 reference

4 April 2018